Exploring Novel Second- and Third-Line Approaches in Metastatic Colorectal Cancer

Christopher Lieu, MD, discusses clinical objectives for third-line mCRC management and patient-specific factors guiding therapeutic strategy.

Benjamin A. Weinberg, MD, FACP, discusses how biomarker status guides third-line treatment selection in mCRC.

Benjamin A. Weinberg, MD, FACP, discusses the specific therapeutic goals and challenges of third-line metastatic colorectal cancer management.

Christopher Lieu, MD, expands on current treatment strategies and factors informing third-line sequencing decisions in mCRC.

Tiago Biachi, MD, PhD, reviews how data from the CORRECT, SUNLIGHT, and FRESCO trials inform later-line treatment selection in refractory mCRC.